Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

H-/K-Ras and N-Ras isoforms were proposed to lack functional specificities due to similarity in 1-165 amino acids. As recent studies implied Ras isoform-specific developmental effects, we examined their functional specificity using Leishmania major infection, anti-hapten antibody response and carrier-specific T cell response. While N-Ras overexpression increased L. major infection in resistant C57BL/6 mice, H-Ras or K-Ras overexpression reduced the infection in susceptible BALB/c mice. These Ras isoforms differentially regulated anti-TNP antibody response in TNP-Ova-primed, but not in TNP-Ficoll- or TNP-LPS-primed, BALB/c mice. Ras isoform-specific silencing selectively modulated Ova-specific T cell response. The data indicate Ras isoform-specific regulation of antigen-specific immune response.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2019.154914DOI Listing

Publication Analysis

Top Keywords

ras isoform-specific
12
ras isoforms
8
antigen-specific immune
8
immune response
8
major infection
8
antibody response
8
cell response
8
balb/c mice
8
mice ras
8
response
6

Similar Publications

KRAS is a pivotal oncoprotein that regulates cell proliferation and survival through interactions with downstream effectors such as RAF1. Despite significant advances in understanding KRAS biology, the structural and dynamic mechanisms of KRAS allostery remain poorly understood. In this study, we employ microsecond molecular dynamics simulations, mutational scanning, and binding free energy calculations together with dynamic network modeling to dissect how engineered DARPin proteins K27, K55, K13, and K19 engage KRAS through diverse molecular mechanisms ranging from effector mimicry to conformational restriction and allosteric modulation.

View Article and Find Full Text PDF

design of Ras isoform selective binders.

bioRxiv

February 2025

Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.

The proto-oncogene Ras which governs diverse intracellular pathways has four major isoforms (KRAS4A, KRAS4B, HRAS, and NRAS) with substantial sequence homology and similar biochemistry. There is considerable interest in investigating the roles of these independently as their association with different cancers vary, but there are few Ras isoform-specific binding reagents as the only significant sequence differences are in their disordered and highly charged C-termini which have been difficult to elicit antibodies against. To overcome this limitation, we use deep learning-based methods to design Ras isoform-specific binders (RIBs) for all major Ras isoforms that specifically target the Ras C-terminus.

View Article and Find Full Text PDF

Structural insights into isoform-specific RAS-PI3Kα interactions and the role of RAS in PI3Kα activation.

Nat Commun

January 2025

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Mutations in RAS and PI3Kα are major drivers of human cancer. Their interaction plays a crucial role in activating PI3Kα and amplifying the PI3K-AKT-mTOR pathway. Disrupting RAS-PI3Kα interaction enhances survival in lung and skin cancer models and reduces tumor growth and angiogenesis, although the structural details of this interaction remain unclear.

View Article and Find Full Text PDF
Article Synopsis
  • Alternative polyadenylation (APA) creates mRNA isoforms of TIMP2 with varying lengths of the 3' untranslated region, which influences protein expression.
  • The long 3'UTR isoform significantly affects the secretion of Timp2 protein compared to the short 3'UTR isoform, which has different localization in the cell.
  • Regulation of these isoforms is crucial in HRAS-driven cell transformation, suggesting that APA plays a vital role in how cells respond to oncogenic signals.
View Article and Find Full Text PDF

RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation.

Eur J Cell Biol

June 2024

Cancer Cell Biology and Drug Discovery group, Department of Life Sciences and Medicine, University of Luxembourg, Esch-sur-Alzette 4362, Luxembourg. Electronic address:

The RAS-MAPK-pathway is aberrantly regulated in cancer and developmental diseases called RASopathies. While typically the impact of Ras on the proliferation of various cancer cell lines is assessed, it is poorly established how Ras affects cellular differentiation. Here we implement the C2C12 myoblast cell line to systematically study the effect of Ras mutants and Ras-pathway drugs on differentiation.

View Article and Find Full Text PDF